KIT and breast carcinoma: We previously observed elevated levels of VEGFR1+CD11b+ [26], KIT+CD11b+ [27] and JAM1+CD11b+ (unpublished data) in murine models of breast cancer and TIE2+CD11b+ cells in mBC cancer patients [28].